Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Rafał Stec

5PUBLICATIONS

31CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Oct 24, 2025

A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies.

Dejan Juric, Daniel Anderson, Afshin Dowlati

|Aug 28, 2025

Prehabilitation Prior to Chemotherapy in Humans: A Review of Current Evidence and Future Directions.

Karolina Pietrakiewicz, Rafał Stec, Jacek Sobocki

|Jan 08, 2025

Theranostics in Renal Cell Carcinoma-A Step Towards New Opportunities or a Dead End-A Systematic Review.

Katarzyna Jóźwik-Plebanek, Marek Saracyn, Maciej Kołodziej

|Sep 14, 2024

The Role of circHIPK3 in Tumorigenesis and Its Potential as a Biomarker in Lung Cancer.

Eryk Siedlecki, Piotr Remiszewski, Rafał Stec

|Nov 14, 2023

Defining Tumor Microenvironment as a Possible Target for Effective GEP-NENs Immunotherapy-A Systematic Review.

Paulina Chmiel, Paulina Rychcik-Pazyrska, Rafał Stec

Pageof 1

Frequent Collaborators

1 joint publications

Eryk Siedlecki

1 joint publications

Katarzyna Jóźwik-Plebanek

1 joint publications

Maciej Kołodziej

1 joint publications

Adam Daniel Durma

1 joint publications

Weronika Mądra

1 joint publications

Marek Dedecjus

1 joint publications

Grzegorz Kamiński

1 joint publications

Karolina Pietrakiewicz

1 joint publications

Jacek Sobocki

1 joint publications

Dejan Juric

Frequent Collaborators

1 joint publications

Eryk Siedlecki

1 joint publications

Katarzyna Jóźwik-Plebanek

1 joint publications

Maciej Kołodziej

1 joint publications

Adam Daniel Durma

Top Related Videos

SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on : Nov 01, 2019

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on : Jun 21, 2024

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

See more related videos

Top Related Videos

SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on : Nov 01, 2019

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting

Published on : Jun 21, 2024

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on : Apr 12, 2017

See more related videos